BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 1373283)

  • 1. HIV-1 reverse transcriptase inhibition by a dipyridodiazepinone derivative: BI-RG-587.
    Tramontano E; Cheng YC
    Biochem Pharmacol; 1992 Mar; 43(6):1371-6. PubMed ID: 1373283
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A novel dipyridodiazepinone inhibitor of HIV-1 reverse transcriptase acts through a nonsubstrate binding site.
    Wu JC; Warren TC; Adams J; Proudfoot J; Skiles J; Raghavan P; Perry C; Potocki I; Farina PR; Grob PM
    Biochemistry; 1991 Feb; 30(8):2022-6. PubMed ID: 1705436
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Human immunodeficiency virus reverse transcriptase. Substrate and inhibitor kinetics with thymidine 5'-triphosphate and 3'-azido-3'-deoxythymidine 5'-triphosphate.
    Reardon JE; Miller WH
    J Biol Chem; 1990 Nov; 265(33):20302-7. PubMed ID: 1700787
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Steady state kinetics and inhibition of HIV-1 reverse transcriptase by a non-nucleoside dipyridodiazepinone, BI-RG-587, using a heteropolymeric template.
    Kopp EB; Miglietta JJ; Shrutkowski AG; Shih CK; Grob PM; Skoog MT
    Nucleic Acids Res; 1991 Jun; 19(11):3035-9. PubMed ID: 1711678
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inhibition of human immunodeficiency virus type 1 (HIV-1) replication by the dipyridodiazepinone BI-RG-587.
    Koup RA; Merluzzi VJ; Hargrave KD; Adams J; Grozinger K; Eckner RJ; Sullivan JL
    J Infect Dis; 1991 May; 163(5):966-70. PubMed ID: 1708400
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Kinetics of inhibition of human immunodeficiency virus type 1 (HIV-1) reverse transcriptase by the novel HIV-1-specific nucleoside analogue [2',5'-bis-O-(tert-butyldimethylsilyl)-beta-D-ribofuranosyl]-3'-spiro-5 "- (4"-amino-1",2"-oxathiole-2",2"-dioxide)thymine (TSAO-T).
    Balzarini J; Pérez-Pérez MJ; San-Félix A; Camarasa MJ; Bathurst IC; Barr PJ; De Clercq E
    J Biol Chem; 1992 Jun; 267(17):11831-8. PubMed ID: 1376314
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The binding of a novel bisheteroarylpiperazine mediates inhibition of human immunodeficiency virus type 1 reverse transcriptase.
    Dueweke TJ; Kézdy FJ; Waszak GA; Deibel MR; Tarpley WG
    J Biol Chem; 1992 Jan; 267(1):27-30. PubMed ID: 1370445
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In vitro selection and molecular characterization of human immunodeficiency virus-1 resistant to non-nucleoside inhibitors of reverse transcriptase.
    Mellors JW; Dutschman GE; Im GJ; Tramontano E; Winkler SR; Cheng YC
    Mol Pharmacol; 1992 Mar; 41(3):446-51. PubMed ID: 1372083
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Synergistic inhibition of human immunodeficiency virus type 1 replication in vitro by two-drug and three-drug combinations of 3'-azido-3'-deoxythymidine, phosphonoformate, and 2',3'-dideoxythymidine.
    Kong XB; Zhu QY; Ruprecht RM; Watanabe KA; Zeidler JM; Gold JW; Polsky B; Armstrong D; Chou TC
    Antimicrob Agents Chemother; 1991 Oct; 35(10):2003-11. PubMed ID: 1722077
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mutational analysis of two conserved sequence motifs in HIV-1 reverse transcriptase.
    Lowe DM; Parmar V; Kemp SD; Larder BA
    FEBS Lett; 1991 May; 282(2):231-4. PubMed ID: 1709876
    [TBL] [Abstract][Full Text] [Related]  

  • 11. DNA chain termination activity and inhibition of human immunodeficiency virus reverse transcriptase by carbocyclic 2',3'-didehydro-2',3'-dideoxyguanosine triphosphate.
    Orr DC; Figueiredo HT; Mo CL; Penn CR; Cameron JM
    J Biol Chem; 1992 Feb; 267(6):4177-82. PubMed ID: 1371285
    [TBL] [Abstract][Full Text] [Related]  

  • 12. 3'-Azido-3'-deoxythymidine triphosphate as an inhibitor and substrate of purified human immunodeficiency virus reverse transcriptase.
    St Clair MH; Richards CA; Spector T; Weinhold KJ; Miller WH; Langlois AJ; Furman PA
    Antimicrob Agents Chemother; 1987 Dec; 31(12):1972-7. PubMed ID: 2449866
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pyridinone derivatives: specific human immunodeficiency virus type 1 reverse transcriptase inhibitors with antiviral activity.
    Goldman ME; Nunberg JH; O'Brien JA; Quintero JC; Schleif WA; Freund KF; Gaul SL; Saari WS; Wai JS; Hoffman JM
    Proc Natl Acad Sci U S A; 1991 Aug; 88(15):6863-7. PubMed ID: 1713693
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inhibitory effect of N3-methyl derivative of 3'-azido-3'-deoxythymidine 5'-triphosphate on the activity of HIV-1 reverse transcriptase.
    Nakane H; Suzuki A; Nakata Y; Kitade Y; Hirota K; Maki Y; Ono K
    Nucleic Acids Symp Ser; 1991; (25):27-8. PubMed ID: 1726810
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Fluorometric measurement of reverse transcriptase activity with 4',6-diamidino-2-phenylindole.
    Chavan SJ; Prochaska HJ
    Anal Biochem; 1995 Feb; 225(1):54-9. PubMed ID: 7539986
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhibition of HIV-1 reverse transcriptase by 5'-triphosphates of 5-substituted uridine analogs.
    Tao PZ; Johansson NG; Stening G; Oberg B; Datema R
    Antiviral Res; 1989 Dec; 12(5-6):269-78. PubMed ID: 2483878
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Human immunodeficiency virus type 1 reverse transcriptase. 3'-Azidodeoxythymidine 5'-triphosphate inhibition indicates two-step binding for template-primer.
    Jaju M; Beard WA; Wilson SH
    J Biol Chem; 1995 Apr; 270(17):9740-7. PubMed ID: 7537269
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inhibition of HIV-1 reverse transcriptase by a quinazolinone and comparison with inhibition by pyridinones. Differences in the rates of inhibitor binding and in synergistic inhibition with nucleoside analogs.
    Carroll SS; Stahlhut M; Geib J; Olsen DB
    J Biol Chem; 1994 Dec; 269(51):32351-7. PubMed ID: 7528214
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inhibition of HIV-1 replication by a nonnucleoside reverse transcriptase inhibitor.
    Merluzzi VJ; Hargrave KD; Labadia M; Grozinger K; Skoog M; Wu JC; Shih CK; Eckner K; Hattox S; Adams J
    Science; 1990 Dec; 250(4986):1411-3. PubMed ID: 1701568
    [TBL] [Abstract][Full Text] [Related]  

  • 20. BI-RG-587 is active against zidovudine-resistant human immunodeficiency virus type 1 and synergistic with zidovudine.
    Richman D; Rosenthal AS; Skoog M; Eckner RJ; Chou TC; Sabo JP; Merluzzi VJ
    Antimicrob Agents Chemother; 1991 Feb; 35(2):305-8. PubMed ID: 1708976
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.